Pharmaceutical News and Articles

Urgent Care Visits Often Linked to Inappropriate Prescribing

Urgent care visits are often associated with inappropriate prescriptions of antibiotics, glucocorticoids, and opioids, according to a research letter published

Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor ag

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Praxis Precision Medicines, Inc. (NASDAQ PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ce

Insomnia Plays a Role in Quality of Life for Patients With ADHD

Attention-deficit hyperactivity disorder (ADHD) symptoms are associated with lower quality of life (QoL) in adults, and this association is only partially media

Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer

Version nine of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control staging system (AJCC9V) human papillomavirus (HPV)-posi

GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension

For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical

Millions of Backyard Pools Recalled After Drowning Deaths of Nine Children

MONDAY, July 21, 2025 Close to 5 million above-ground swimming pools have been recalled following the drowning deaths of nine children over two decades. The 48-

FDA Elevates Dubai Chocolate Spread Recall to Class 1 Over Salmonella Risk

MONDAY, July 21, 2025 The U.S. Food and Drug Administration (FDA) has escalated the recall of a popular Dubai chocolate spread sold nationwide to its highest al

Cannabis Use Disorder May Up Risk of Benign Salivary Gland Tumors

Cannabis use disorder (CUD) is associated with increased risk of benign salivary gland tumors, according to a research letter published online July 17 in JAMA O

Johnson & Johnson Seeks First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis